Judicial Panel Transfers the First 53 Cases

Judicial Panel Transfers the First 53 Cases
Aug 5, 2013 Gayle Gerling Pettinga Read Time: < 1 minute

August 2013 — In August 2013, the Judicial Panel on Multidistrict Litigation transferred the first 53 cases against Merck, Amylin, Eli Lilly and Novo Nordisk to MDL No. 2452. The original cases came from state courts in Arizona, California, Colorado, Kansas, Missouri, Oklahoma and Pennsylvania.

Since all of the lawsuits claim the drugs caused pancreatic cancer and pancreatitis, the court felt it would be more efficient to centralize the cases because they all would likely use the same experts and go through the same discovery process.

Reference:  “Januvia, Byetta and Victoza Lawsuits – MDL History & Appeals.” Drugwatch.com, 20 Apr. 2020, www.drugwatch.com/januvia/lawsuits/.

By: Gayle Gerling Pettinga

Born and raised in Evansville, Gayle is a respected, experienced lawyer and a valued community leader. She graduated near the top of her class at Indiana University’s prestigious Maurer School of Law. She’s practiced law with one of the largest firms in Indianapolis as well as one of the largest pharmaceutical companies in the world. And that means she knows how big law firms and big companies think and how they operate – and she will put that knowledge to work for you.

Gayle has received numerous awards and honors including Martindale-Hubbell — Peer Review Rated: AV®, American Institute of Personal Injury Attorneys 10 Best Attorneys in Indiana for Exceptional and Outstanding Client Service, and YWCA Evansville 100 Years, 100 Women Honoree, 2011.

(888) 437-5464
Jump to a Topic  Schedule Your Free Consultation